Home > Qtrly Results > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]

LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹168 Cr ₹147 Cr ₹161 Cr ₹147 Cr ₹142 Cr ₹146 Cr ₹156 Cr ₹136 Cr
Expenses ₹141 Cr ₹123 Cr ₹133 Cr ₹125 Cr ₹124 Cr ₹117 Cr ₹125 Cr ₹115 Cr
Operating Income ₹27 Cr ₹24 Cr ₹28 Cr ₹23 Cr ₹18 Cr ₹30 Cr ₹31 Cr ₹21 Cr
Other Income ₹-7 Cr ₹9 Cr ₹10 Cr ₹10 Cr ₹7 Cr ₹11 Cr ₹9 Cr ₹8 Cr
Interest ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Profit Before Tax ₹16 Cr ₹29 Cr ₹35 Cr ₹29 Cr ₹22 Cr ₹38 Cr ₹37 Cr ₹25 Cr
Profit After Tax ₹12 Cr ₹21 Cr ₹26 Cr ₹24 Cr ₹19 Cr ₹28 Cr ₹28 Cr ₹19 Cr
EPS ₹5.78 ₹10.37 ₹13.15 ₹11.82 ₹9.28 ₹14.00 ₹13.81 ₹9.49
Industry Peers & Returns1W1M1Y
LINCOLN PHARMACEUTICALS -3% -4.4% -4.9%
SUN PHARMACEUTICAL INDUSTRIES 0.2% -8.3% 15.9%
DIVIS LABORATORIES -1.9% 8.6% 55.9%
CIPLA -1.3% -5.5% -0.1%
TORRENT PHARMACEUTICALS -0.5% -4.2% 19.3%
DR REDDYS LABORATORIES 0.7% 5.8% 6.1%
MANKIND PHARMA 1.8% 0.4% 16.6%
ZYDUS LIFESCIENCES 1.9% 4.8% -12.7%
LUPIN -1.5% -6.5% 21.9%

LINCOLN PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

14.76 %

Y-o-Y

18.03 %

Quarters Revenues % Change
Mar2025 ₹168 Cr
14.76
Dec2024 ₹147 Cr
-9.09
Sep2024 ₹161 Cr
9.46
Jun2024 ₹147 Cr
3.36
Mar2024 ₹142 Cr
-2.70
Dec2023 ₹146 Cr
-6.12
Sep2023 ₹156 Cr
15.02
Jun2023 ₹136 Cr -

LINCOLN PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

12.91 %

Y-o-Y

45.35 %

Quarters Operating Profit % Change
Mar2025 ₹27 Cr
12.91
Dec2024 ₹24 Cr
-16.62
Sep2024 ₹28 Cr
24.85
Jun2024 ₹23 Cr
23.66
Mar2024 ₹18 Cr
-38.02
Dec2023 ₹30 Cr
-4.78
Sep2023 ₹31 Cr
50.34
Jun2023 ₹21 Cr -
Operating Margins
Q-o-Q

-1.61 %

Y-o-Y

23.18 %

Quarters Operating Margin% % Change
Mar2025 15.89%
-1.61
Dec2024 16.15%
-8.24
Sep2024 17.6%
14.06
Jun2024 15.43%
19.61
Mar2024 12.9%
-36.30
Dec2023 20.25%
1.40
Sep2023 19.97%
30.69
Jun2023 15.28% -

LINCOLN PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-44.28 %

Y-o-Y

-37.76 %

Quarters Profit After Tax % Change
Mar2025 ₹12 Cr
-44.28
Dec2024 ₹21 Cr
-21.12
Sep2024 ₹26 Cr
11.23
Jun2024 ₹24 Cr
27.29
Mar2024 ₹19 Cr
-33.67
Dec2023 ₹28 Cr
1.39
Sep2023 ₹28 Cr
45.44
Jun2023 ₹19 Cr -
PAT Margins
Q-o-Q

-51.45 %

Y-o-Y

-47.28 %

Quarters PAT Margin(%) % Change
Mar2025 6.88 %
-51.45
Dec2024 14.17 %
-13.23
Sep2024 16.33 %
1.62
Jun2024 16.07 %
23.14
Mar2024 13.05 %
-31.85
Dec2023 19.15 %
8.01
Sep2023 17.73 %
26.46
Jun2023 14.02 % -

LINCOLN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-44.26 %

Y-o-Y

-37.72 %

Quarters EPS % Change
Mar2025 ₹5.78
-44.26
Dec2024 ₹10.37
-21.14
Sep2024 ₹13.15
11.25
Jun2024 ₹11.82
27.37
Mar2024 ₹9.28
-33.71
Dec2023 ₹14
1.38
Sep2023 ₹13.81
45.52
Jun2023 ₹9.49 -

You may also like the below Video Courses